Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
US8039003B2 · kind B2 · utility
6Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2009 |
| Grant date | Oct 18, 2011 |
| Priority date | — |
| Expiry date | Oct 26, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions featuring an attenuated dengue virus mutant or an attenuated chimeric dengue virus mutant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.